Evoke Pharma (EVOK) Tops Q4 EPS by 8c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance
• Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance